Conditions: Bariatric Surgery
Keywords: Gastric Bypass Duloxetine Cymbalta Pharmacokinetics
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: yes

Brief summary:
This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.

Detailed description:

Arms:
arm 1: All subjects received drug. Single arm.

Interventions: intervention 1: Duloxetine
Intervention descriptions: intervention 1: Single dose of 60 mg of duloxetine

Protocol document: